WCN26-476 SCO-792, an enteropeptidase inhibitor, attenuated renal and hepatic cyst progression in a mouse model of autosomal dominant polycystic kidney disease

Read full text Summarise with VIRAT
Authors: Takuro Kawamura, Fumihiko Hattanda, Shun Takenaka, Kanako Watanabe‐Kusunoki, Jun Sugama, Yusuke Moritoh, Masanori Watanabe, Daigo Nakazawa, Tatsuya Atsumi, Saori Nishio
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Amino acids, especially branched-chain amino acids (BCAAs), are key regulator of the mammalian target of the rapamycin (mTOR). Excessive administration of BCAAs to the PKD-1 knockout mice accelerates kidney and hepatic cyst formation via the mTOR activation, leading to exacerbated renal function. SCO-792, an enteropeptidase inhibitor, decreases amino acid uptake by preventing the enzymatic breakdown of dietary proteins into absorbable amino acids, which has been shown to lower serum BCAA levels and suppress the mTOR cascade in a mouse model of diabetic kidney disease.

Fields of Study & Subjects

Genetic and Kidney Cyst Diseases Tuberous Sclerosis Complex Research Cystic Fibrosis Research Advances

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105079–105079
Publication date
25 March 2026
Language
EN